• Bilali Habeş Gümüş, Ali Can Albaz, Fatih Düzgün, Oktay Üçer, Gökhan Temeltaş, Talha Müezzinoğlu, and Serdar Tarhan.
• Department of Urology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey.
• Int. J. Clin. Pract. 2021 Jul 1; 75 (7): e14130.

ObjectiveThe aim of this study is to evaluate the outcome of ablation therapy in our clinic for the treatment of patients with a small renal mass Materials and Methods: We retrospectively evaluated the technic and follow-up data of 30 patients with 36 tumours who underwent Radiofrequency Ablation (RFA) and Microwave Ablation (MWA) in our clinic. Demographic data, ablation type, tumour characteristics, peroperative and postoperative complications and treatment success of the patients were evaluated.ResultsA total of 36 tumours who underwent ablation treatments, 23 were treated with RFA, 13 with MWA. The mean tumour size was 28.9 ± 6.92 mm in RFA and 29.3 ± 7.70 mm in MWA. The mean follow-up period was 49.6 ± 24.7 months in patients with RFA and mean follow-up was 16 ± 8.05 months in MWA treatments. The overall success in MWA administration was calculated as 76.9%, while the overall success in RFA was 80%.ConclusionLong-term oncologic efficacy of RFA appears to be successful in the treatment of T1a renal carcinomas. Further studies can be conducted to elucidate the influence of MWA on long-term oncological outcomes.© 2021 John Wiley & Sons Ltd.

8 keywords...

hide…